Peter Barton Hutt
Insider
First SEC filing: May 22, 2017 · Latest: May 22, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2019 | MRNA | M | 200,000 | · | · | 502,752 Direct | -28.46% | Disposed | (price as of 2026-10-02) |
| Nov. 20, 2019 | MRNA | S | 200,000 | $20.18 | $4,036,000 | 3,924 Direct | -98.08% | Disposed | 841.6% (price as of 2026-10-02) |
| Nov. 20, 2019 | MRNA | M | 200,000 | $0.04 | $8,000 | 203,924 Direct | +5096.84% | Acquired | 474925.0% (price as of 2026-10-02) |
| Sept. 17, 2019 | MRNA | M | 100,000 | · | · | 702,752 Direct | -12.46% | Disposed | (price as of 2026-10-02) |
| Sept. 17, 2019 | MRNA | S | 100,000 | $17.63 | $1,763,000 | 3,924 Direct | -96.22% | Disposed | 977.8% (price as of 2026-10-02) |
| Sept. 17, 2019 | MRNA | M | 100,000 | $0.04 | $4,000 | 103,924 Direct | +2548.42% | Acquired | 474925.0% (price as of 2026-10-02) |
| June 27, 2019 | MRNA | A | 54,660 | · | · | 54,660 Direct | · | Acquired | (price as of 2026-10-02) |
| July 25, 2018 | DCOY | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 15, 2018 | RNAC | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 26, 2017 | DCOY | A | 12,000 | · | · | 12,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 16, 2017 | RNAC | A | 6,410 | · | · | 6,410 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 10, 2017 | XOMA | A | 8,000 | · | · | 8,000 Direct | · | Acquired | |
| July 21, 2016 | XOMA | A | 121,064 | · | · | 121,064 Direct | · | Acquired | |
| June 15, 2016 | MCRB | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 8, 2016 | DCOY | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 29, 2015 | DCOY | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 25, 2015 | MCRB | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 21, 2015 | XOMA | A | 73,746 | $3.39 | $249,999 | 73,746 Direct | · | Acquired | |
| Feb. 3, 2015 | DCOY | C | 11,675 | · | · | 11,675 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 3, 2015 | DCOY | C | 50,000 | · | · | 0 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 12, 2014 | XOMA | A | 12,500 | $4.73 | $59,125 | 12,500 Direct | · | Acquired | |
| May 22, 2014 | XOMA | A | 20,000 | $3.87 | $77,400 | 20,000 Direct | · | Acquired | |
| May 23, 2013 | XOMA | A | 20,000 | $4.13 | $82,600 | 20,000 Direct | · | Acquired | |
| May 24, 2012 | XOMA | A | 20,000 | $2.36 | $47,200 | 20,000 Direct | · | Acquired | |
| Oct. 27, 2011 | XOMA | A | 35,087 | $1.69 | $59,297 | 35,087 Direct | · | Acquired | |
| May 26, 2011 | XOMA | A | 5,000 | $3.03 | $15,150 | 5,000 Direct | · | Acquired | |
| Jan. 7, 2011 | XOMA | A | 11,940 | $5.83 | $69,610 | 11,940 Direct | · | Acquired | |
| July 21, 2010 | XOMA | A | 75,000 | $0.35 | $26,250 | 75,000 Direct | · | Acquired | |
| May 21, 2009 | XOMA | A | 35,000 | $0.76 | $26,600 | 35,000 Direct | · | Acquired | |
| Oct. 23, 2008 | XOMA | A | 5,000 | $1.58 | $7,900 | 5,000 Direct | · | Acquired | |
| May 13, 2008 | XOMA | A | 25,000 | · | · | 25,000 Direct | · | Acquired | |
| Feb. 21, 2008 | XOMA | A | 93,600 | · | · | 93,600 Direct | · | Acquired | |
| Feb. 21, 2008 | XOMA | A | 93,600 | · | · | 93,600 Direct | · | Acquired | |
| May 22, 2007 | XOMA | A | 12,000 | · | · | 12,000 Direct | · | Acquired | |
| May 23, 2006 | XOMA | A | 10,000 | · | · | 10,000 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 20, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock | $0.04 | March 27, 2022 | 200,000 | Disposed |
| Sept. 17, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock | $0.04 | March 27, 2022 | 100,000 | Disposed |
| June 27, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock | $14.34 | June 27, 2029 | 54,660 | Acquired |
| July 25, 2018 | DCOY | Stock Option (right to buy) | Common Stock | $0.82 | July 25, 2028 | 10,000 | Acquired |
| June 15, 2018 | RNAC | Stock Option (Right to Buy) | Common Stock | $12.75 | June 14, 2028 | 10,000 | Acquired |
| July 26, 2017 | DCOY | Stock Option (right to buy) | Common Stock | $4.08 | July 26, 2027 | 12,000 | Acquired |
| June 16, 2017 | RNAC | Stock Option (Right to Buy) | Common Stock | $17.47 | June 15, 2027 | 6,410 | Acquired |
| Feb. 10, 2017 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $4.03 | Feb. 10, 2027 | 8,000 | Acquired |
| July 21, 2016 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $0.56 | July 21, 2026 | 121,064 | Acquired |
| June 15, 2016 | MCRB | Stock Option (right to buy) | Common Stock | $30.24 | June 14, 2026 | 15,000 | Acquired |
| June 8, 2016 | DCOY | Stock Option (right to buy) | Common Stock | $12.21 | June 8, 2026 | 10,000 | Acquired |
| June 29, 2015 | DCOY | Stock Option (right to buy) | Common Stock | $17.43 | June 29, 2025 | 10,000 | Acquired |
| June 25, 2015 | MCRB | Stock Option (right to buy) | Common Stock | $18.00 | June 24, 2025 | 15,000 | Acquired |
| May 21, 2015 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $3.39 | May 21, 2025 | 73,746 | Acquired |
| Feb. 3, 2015 | DCOY | Series A Preferred Stock | Common Stock | $0.00 | · | 50,000 | Acquired |
| Sept. 12, 2014 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $4.73 | Sept. 12, 2024 | 12,500 | Acquired |
| May 22, 2014 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $3.87 | May 22, 2024 | 20,000 | Acquired |
| May 23, 2013 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $4.13 | May 23, 2023 | 20,000 | Acquired |
| May 24, 2012 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $2.36 | May 24, 2022 | 20,000 | Acquired |
| Oct. 27, 2011 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $1.69 | Oct. 27, 2021 | 35,087 | Acquired |
| May 26, 2011 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $3.03 | May 26, 2021 | 5,000 | Acquired |
| Jan. 7, 2011 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $5.83 | Jan. 7, 2021 | 11,940 | Acquired |
| July 21, 2010 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $0.35 | July 21, 2020 | 75,000 | Acquired |
| May 21, 2009 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $0.76 | May 21, 2019 | 35,000 | Acquired |
| Oct. 23, 2008 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $1.58 | Oct. 23, 2018 | 5,000 | Acquired |
| May 13, 2008 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $2.10 | May 13, 2018 | 25,000 | Acquired |
| Feb. 21, 2008 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $2.71 | Feb. 21, 2018 | 93,600 | Acquired |
| Feb. 21, 2008 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $2.71 | Feb. 21, 2018 | 93,600 | Acquired |
| May 22, 2007 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $3.42 | May 22, 2017 | 12,000 | Acquired |
| May 23, 2006 | XOMA | Non-Qualified Share Option (right to buy) | Common Shares | $1.70 | May 23, 2016 | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 17 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 7, 2018 | MRNA | Common Stock | 3,924 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy) | 802,752 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy) | 23,853 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy) | 9,263 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy) | 42,201 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy) | 40,307 | Direct |
| June 21, 2016 | RNAC | Stock Option (right to buy) | 20,512 | Direct |
| June 21, 2016 | RNAC | Stock Option (right to buy) | 24,358 | Direct |
| June 25, 2015 | MCRB | Common Stock | 50,000 | Direct |
| June 25, 2015 | MCRB | Stock Option (right to buy) | 50,000 | Direct |
| Jan. 30, 2015 | DCOY | Stock Option (right to buy) | 28,021 | Direct |
| Jan. 30, 2015 | DCOY | Stock Option (right to buy) | 7,005 | Direct |
| Jan. 30, 2015 | DCOY | Series A Preferred Stock | 50,000 | Direct |
| Jan. 28, 2015 | DCOY | Stock Option (right to buy) | 28,021 | Direct |
| Jan. 28, 2015 | DCOY | Stock Option (right to buy) | 7,005 | Direct |
| Jan. 28, 2015 | DCOY | Series A Preferred Stock | 50,000 | Direct |
| May 23, 2005 | XOMA | Non-Qualified Share Option (right to buy) | 20,000 | Direct |